December 26, 2025

Tectonic Therapeutic, Inc. (TECX): Investor Outlook with a Potential 261% Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to targeting G protein-coupled receptors (GPCRs)...

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a Promising 26.73% Upside in the Biotech Sector

Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing the attention of investors with its potential for significant growth in the healthcare sector. As a clinical-stage biotechnology company,..

AnaptysBio, Inc. (ANAB) Stock Analysis: 30% Upside Potential with Strong Analyst Support

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company, has been capturing investor attention with its impressive growth metrics and a substantial potential upside. Based in San..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring the 110% Potential Upside and Strategic Growth in Gene Therapy

REGENXBIO Inc. (RGNX), a pioneering player in the biotechnology sector, has been capturing attention with its innovative approach to gene therapy. Based in Rockville, Maryland, this..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Unpacking a Potential 82.5% Upside in Gene Therapy Innovation

For investors looking to capitalize on the burgeoning field of biotechnology, Taysha Gene Therapies, Inc. (TSHA) presents an intriguing opportunity. This Dallas-based company, with a market..

uniQure N.V. (QURE) Stock Analysis: Exploring a 120.75% Potential Upside in Gene Therapy Innovation

uniQure N.V. (NASDAQ: QURE), a Dutch biotechnology company, emerges as a noteworthy player in the healthcare sector, focusing on pioneering gene therapies for rare and severe..

Immatics N.V. (IMTX) Stock Analysis: Riding the Biotechnology Wave with an 80.81% Potential Upside

German biopharmaceutical company Immatics N.V. (NASDAQ: IMTX) is making waves in the biotechnology sector with its cutting-edge approach to cancer treatment. At the heart of the..

Community Health Systems, Inc. (CYH) Stock Analysis: Unpacking a 21.72% Potential Upside Amidst Healthcare Volatility

Community Health Systems, Inc. (NYSE: CYH) presents a complex yet intriguing opportunity for investors looking to tap into the healthcare sector. With its operations deeply embedded..

Claritev Corporation (CTEV) Stock Analysis: A 99% Upside Beckons as Analysts Rally Behind Healthcare Innovator

Claritev Corporation (CTEV) is capturing the attention of investors with its robust potential for growth, particularly in the burgeoning sector of healthcare information services. Headquartered in..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring a 71% Upside Potential in Biotechnology

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is drawing significant attention in the biotechnology sector, not just for its ambitious therapeutic developments but also for its remarkable potential..

Sana Biotechnology, Inc. (SANA) Stock Analysis: A Biotech with 89% Potential Upside

Sana Biotechnology, Inc. (NASDAQ: SANA), a cutting-edge player in the biotechnology sector, is capturing investor attention with its promising potential upside of 89.21%. With a focus..

Embecta Corp. (EMBC) Stock Analysis: Navigating Market Challenges with a 37.97% Upside Potential

Embecta Corp. (NASDAQ: EMBC), a stalwart in the medical instruments and supplies industry, is currently trading at $12.08, reflecting a modest price change of 0.16 (0.01%)...

Arvinas, Inc. (ARVN) Stock Analysis: A Biotech Innovator with Phase 3 Trials on the Horizon

Arvinas, Inc. (NASDAQ: ARVN) is a clinical-stage biotechnology company situated in the healthcare sector, specializing in the innovative field of targeted protein degradation. With a market..

AbCellera Biologics Inc. (ABCL): Analyzing a Promising 164% Upside in the Biotech Sector

AbCellera Biologics Inc. (ABCL) stands out in the biotech industry with its innovative approach to antibody-based medicine discovery. Headquartered in Vancouver, Canada, AbCellera operates in the..

Maravai LifeSciences Holdings (MRVI): Navigating a 19% Potential Upside Amidst Challenging Metrics

For investors seeking opportunities within the biotechnology sector, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a mix of potential and challenges. Based in San Diego, California,..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unveiling a 3,575.80% Revenue Surge and Promising Biotechnology Innovations

Investors with a keen eye on the biotechnology sector should take a closer look at Keros Therapeutics, Inc. (NASDAQ: KROS), a dynamic player in the healthcare..

Immunome, Inc. (IMNM) Stock Analysis: A Promising Biotech Play with 53% Upside Potential

Immunome, Inc. (NASDAQ: IMNM), a biotechnology company specializing in targeted cancer therapies, has been capturing the attention of investors with its robust pipeline and significant upside..

iRadimed Corporation (IRMD) Stock Analysis: Riding High with Strong Revenue Growth and Analyst Confidence

iRadimed Corporation (IRMD), a dynamic player in the healthcare sector specializing in medical devices, has been capturing investor attention with its impressive market performance and solid..

InMode Ltd. (INMD) Stock Analysis: Unveiling Growth Potential Amidst Market Challenges

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically within the medical devices industry, has captured attention with its innovative approach to aesthetic..

CeriBell, Inc. (CBLL) Stock Analysis: A Medical Device Innovator with 31% Revenue Growth and Strong Buy Ratings

CeriBell, Inc. (CBLL) has been making waves in the medical devices industry, focusing on transforming the diagnosis and management of neurological conditions. As a healthcare company..

Search

Funds

December 26, 2025

Search

Funds

December 26, 2025

FTSE 100

Funds